Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for NK- 1
Most Correlated Studies
- GSK cancer cell line transcript profiling
- Natural killer/T-cell lymphoma NKYS cells with JAK3 or EZH2 gene manipulations
- Natural killer/T cell lymphomas with DDX3X mutations
- Natural killer/T cell lymphoma gene expression profiling of 30 patient samples and normal NK cells
- Peripheral T-cell lymphoma OCI-LY 13.2 cells treated with CDK7 covalent inhibitor THZ1
Most Relevant Literature
- Association of Neurokinin-1 Receptor Signaling Pathways with Cancer.
- Rapid elucidation of agonist-driven regulation of the neurokinin 1 receptor using a GPCR phosphoryla…
- Advances in the research and application of neurokinin-1 receptor antagonists.
- Identification of an Intravenous Injectable NK1 Receptor Antagonist for Use in Traumatic Brain Injur…
- NK1 receptor mediates cerebral cellular and extracellular morphological changes during the LPS-induc…
Most Relevant Clinical Trials
- Olanzapine or Dexamethasone, With 5-HT3 RA and NK-1 RA, to Prevent CINV
- Combination of Anti-PD-1 and NK Immunotherapy for Recurrent Solid Tumors
- A Pilot Study of NK Cell Combined With PD-1 Antibody as Second Line Therapy for Advanced Driver Muta…
- A Study To Evaluate An NK-1 Antiemetic For The Prevention Of Post Operative Nausea And Vomiting
- Neurokinin (NK) 1 Antagonist for Pathological Aggression for Harmful, Impulsive, and Self-/Aggressiv…
